Such sgRNA-tiling screen paired with single-cell transcriptional profiling could uncover specific sub-domain regulatory elements in the candidate protein DOT1L that regulates resistance against anti-DOT1L therapy in a leukemia subtype (Yang et al., 2021). The gene discussed is DOT1L; the disease is leukemia.